Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29007666 | 0.93 | ALDH1A1 (0.43) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL30567363 | 0.80 | ALDH1A1 (0.44) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL11282833 | 0.77 | ALDH1A1 (0.46) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL28883523 | 0.74 | ALDH1A1 (0.40) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL31552901 | 0.73 | HDAC8 (0.47) | ALDH1A1SMN1; SMN2KDM4EGAA | |
| SCHEMBL5484638 | 0.73 | HDAC8 (0.47) | ALDH1A1SMN1; SMN2KDM4EGAA | |
| SCHEMBL10374296 | 0.72 | PDE10A (0.58) | ALDH1A1HPGDALOX15HSD17B10PDE10A | |
| Nitrogen SCHEMBL27690667 | 0.71 | HDAC8 (0.44) | ALDH1A1SMN1; SMN2KDM4EGAA | |
| SCHEMBL15911967 | 0.71 | ALDH1A1 (0.43) | ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2 | |
| SCHEMBL20379780 | 0.70 | CA2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108586531-A | A kind of 2- phosphonos quinoxaline compound and preparation method thereof | 郑州大学 | 2018-09-28 | — | — | CN | claimed |
| WO-1999009845-A1 | IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-04 | — | — | WO | claimed |
| US-20230035913-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWTH | VERDESIAN LIFE SCIENCES U.S., LLC | 2023-02-02 | — | — | US | disclosed |
| CN-115334884-A | Chlorodiidine compositions for increasing nitrogen nutrient use efficiency and improving plant growth | 沃戴申生命科学美国有限责任公司 | 2022-11-11 | — | — | CN | disclosed |
| WO-2021141855-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWH | VERDESIAN LIFE SCIENCES U.S., LLC (US) | 2021-07-15 | — | — | WO | disclosed |
| CN-108586531-A | A kind of 2- phosphonos quinoxaline compound and preparation method thereof | 郑州大学 | 2018-09-28 | — | — | CN | disclosed |
| CN-108586531-A | A kind of 2- phosphonos quinoxaline compound and preparation method thereof | 郑州大学 | 2018-09-28 | — | — | CN | disclosed |
| CN-108586531-A | A kind of 2- phosphonos quinoxaline compound and preparation method thereof | 郑州大学 | 2018-09-28 | — | — | CN | disclosed |
| US-6057304-A | Quinoxaline-phosphonic acid derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230035913-A1 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWTH | NANS, PNPO, PNP | ALDH1A1 3821/4885HPGD 522/4885ALOX15 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.